Design Therapeutics Inc
For the period ended Jun 13, 2024. Filed Apr 25, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 13, 2024 · Filed Apr 25, 2024
Use the contents to explore the available documents and sections.
Contents
Overview
The Compensation Committee and the Board administer our compensation programs. Although focused on executive compensation, the Compensation Committee also sets the annual compensation guidelines for all our employees.
Our current principal executive officer, our former principal executive officer, and our only other executive officer during the year ended December 31, 2023 (“Named Executive Officers”) are:
Pratik Shah, Ph.D., our President, Chief Executive Officer and Chairperson,
Sean Jeffries, Ph.D., our Chief Operating Officer, and
João Siffert M.D., our Former President and Chief Executive Officer.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.